Continuing Education Activity

Angioplasty is performed to treat atherosclerotic disease and its resultant complications such as myocardial infarction, strokes, renal failure, and limb ischemia. Radial and femoral are the two common arterial approaches utilized for angioplasty. The main indications for angioplasty include coronary artery disease and peripheral arterial disease. Following angioplasty, stents are often placed to relieve obstructive stenosis. This activity reviews the types of stents typically used in common practice, indications, contraindications, equipment, techniques, personnel, tools, and devices used for angioplasty and percutaneous intervention. It also emphasizes the role of the interprofessional team to optimize procedural outcomes.

Objectives:

• Summarize the equipment used to treat atherosclerotic disease.
• Identify the indications for angioplasty and stent placement.
• Review the various approaches used for angioplasty and their associated complications.

Introduction

Worldwide, atherosclerosis is the most common cause of morbidity and mortality manifesting as cardiovascular disease, carotid artery disease, peripheral vascular disease, and renal artery stenosis.[1] Angioplasty is a minimally invasive endovascular procedure to widen these stenosed arteries. Angioplasty procedures are mainly directed against atherosclerotic plaque to mold and remodel the plaque and subsequently (derived from the Greek terms aging- vessel and plasso-mold). Recent advances in interventional radiology have made it possible to potentially treat almost all anatomic lesions with endovascular means, since its inception in 1964, when Dr.Charles Dotter percutaneously dilated localized stenosis of the subsartorial artery in an 82-year-old female with a guidewire and coaxial Teflon catheter, the tools, and techniques of angioplasty have greatly evolved from simple angioplasty with balloon dilation to stent placement and atherectomy procedures.[2][3][4] 

Some of the types of stents used are:

1. Coronary angioplasty

• Bare metal stent
• Drug-eluting stent
• • Early generation drug-eluting stents: Sirolimus-eluting stent and Paclitaxel-eluting stent
  • Durable polymer drug-eluting stents: Everolimus-eluting stent, Zotarolimus eluting stent, Ridaforolimus-eluting stent
  • Bioabsorbable polymer drug-eluting stents
  • • Thin-strut bioabsorbable polymer DES
    • Ultra-thin strut DES: Orsiro stent
  • Polymer free DES
  • Others: Combo stent - sirolimus elution from biodegradable polymer matrix which is abluminal in shape with a CD34 antibody layer

The choice of stent depends on local availability and interventional cardiologist's expertise - Everolimus-eluting stents, Zotarolimus-eluting stent, ridaforolimus-eluting stents, and the biodegradable stent are usually the first choice. A bare-metal stent is preferred in cases where the patient is actively bleeding, or the duration of dual antiplatelet therapy cannot be >30 days e.g., non-cardiac surgery within 4-6 weeks of PCI.

2. Carotid angioplasty

• Self Expanding Stents
• • Cobalto alloy braided mesh stent
  • Nitinol open-cell stents (cylindrical or tapered)
  • Nitinol closed-cell stents
  • Hybrid nitinol stent
• New Hybrid Carotid Stent

There is no clear guideline on which stent is ideal; there is a trend towards a tailored approach where the choice of stent and procedure is made based on individual carotid anatomy, plaque complexity, anatomopathological variables, and local availability and technical expertise.[5]

3. Peripheral arteries

• Balloon-expandable stents
• Self-expandable stents
• Covered stents
• Drug-eluting stents
• Drug coated balloon stent
• Dual therapy stents
• Bioabsorbable vascular scaffold
• Bioengineered stent[6]

The choice of an appropriate stent depends on the access site, lesion location, stent availability, plaque complexity, and vascular anatomy evaluation, and expertise of the operator.[7]

Angioplasty is sometimes combined with atherectomy procedures to remove the plaque using specialized devices. Types of atherectomy procedures are Mechanical: Directional, Rotational, or Orbital devices or Laser evaporative methods that require the use of costly disposable devices. Evidence regarding their efficacy is lacking, and their use is still under investigation in specific niche indications.

Anatomy and Physiology

Atherosclerosis is characterized by the formation of fibrofatty plaques consisting of cholesterol-laden macrophages, calcium, fibrous tissue, tissue matrix, and cellular debris deposits in the intima of blood vessels.[8] When this plaque increases in size, it disrupts blood flow resulting in characteristic symptoms of distal ischemia. An acute increase in this plaque size, e.g., due to hemorrhage into the plaque or rupture followed by platelet-rich thrombus formation, results in acute ischemia and risks distal necrosis.

Angioplasty aims to compress the plaque with a balloon or stent and open the stenosed artery to relieve distal ischemia. One of the major complications of stent placement is the risk of thrombosis of the stent, which is overcome by dual antiplatelet therapy administration. Another complication of stent placement is the possibility of neointimal hyperplasia and stent restenosis, which is overcome by a coating of the stent with antiproliferative drugs like sirolimus, tacrolimus, or everolimus, which lead to the evolution of DES. Late stent placement complications occur due to the presence of metallic structure in the strut of the stent, which leads to restenosis and late stent thrombosis. This is overcome by biodegradable polymer stents, which have less risk of long-term in-stent restenosis and thrombosis, but the reduced vascular recoil limits their utility. Therefore, the choice of the stent is highly specific to each artery and type of plaque and local expertise in accurate stent placement.

Indications

Coronary Angioplasty and Stent Placement

Acute coronary syndromes: Unstable angina, STEMI, and NSTEMI. In stable coronary artery disease, indications for PCI are: Activity limiting symptoms despite optimal medical therapy, Active patients who prefer PCI for improvement in the quality of life, and single-vessel disease involving right coronary and left circumflex coronary arteries or two-vessel disease involving right coronary and left circumflex arteries. For left main disease or multivessel disease in patients who have diabetes - CABG is preferred over PCI.[9][10][11]

Carotid Angioplasty

Revascularization is primarily indicated in patients with symptomatic carotid stenosis of >70% to 99%.[12][13] In general carotid endarterectomy has less peri-procedure stroke rates than stenting.[14] Patient subgroups who have better outcomes with carotid stenting are - Prior neck irradiation, high cervical carotid bifurcation, or 100% occlusion of the contralateral internal carotid artery.

Peripheral Vascular Disease

Patients with disabling symptoms, despite lifestyle adjustment, supervised exercise programs, and pharmacotherapy, are candidates for revascularization. The choice of revascularization procedure depends on symptomatology, patient risk, location and extent of disease, comorbidities, patient's functional status, and patient preference. Angioplasty with stenting is the preferred procedure except in cases of - Eccentric calcified stenosis, a long segment of stenosis, or multifocal stenosis.[15][16]

Renal Artery Stenosis

Angioplasty with stenting is the preferred treatment for patients with renovascular disease with uncontrolled hypertension despite maximally tolerated medical therapy.

AV Fistula Stenosis 

Angioplasty is sometimes used to treat venous stenosis associated with hemodialysis access.[17]

Contraindications

General contraindications of angioplasty procedure are small size vessels, posterior calcification, occlusion, or hematoma of vessels, inability to tolerate dual antiplatelet therapy or allergy to stent components. 

Carotid angioplasty is relatively contraindicated in the elderly (>80y.o) due to the high risk of stroke.[18]

A relative contraindication includes significant comorbidities that severely limit life expectancy.

Equipment

We need the following equipment:

• Fluoroscopy and X-ray imaging equipment (including radiographic table, two X-ray tubes, fluoroscopy screen)
• Micropuncture needle (18-20G)
• Hydrophilic sheath
• Contrast material 
• Guidewire
• Balloon catheter
• The stent of an appropriate type and size
• Ultrasound imaging device
• Hemodynamic monitoring system

Preparation

The patient is evaluated by the vascular surgeon/ interventional cardiologist to determine eligibility and determine the most appropriate procedure (plain angioplasty, stent placement, and type of stent, atherectomy). Usually, this does not require anesthesia and, therefore, does not require pre-procedure evaluation by an anesthesiologist unless the patient has a high Mallampati score. When involved, an anesthesiologist evaluates the patient for the determination of the risk of the procedure and assessment to optimize medication and medical conditions.

It is important to evaluate patient allergies (to iodinated contrast) and medication compliance. It is important to evaluate renal function in these patients as these procedures require a significant amount of contrast material for appropriate visualization throughout the procedure. Preoperatively, any nephrotoxic medications are held, including NSAIDs, ACE inhibitors, loop diuretics, and metformin.

Anticoagulants (warfarin, rivaroxaban, apixaban) are also withheld before surgery, and the patient is premedicated with aspirin alone or in combination with ticagrelor/ prasugrel/clopidogrel. The patient is made NPO for 8-12hr before the procedure. A few hours before the procedure, the patient is evaluated for hemodynamic stability and monitored continuously throughout the procedure. The procedure area is prepared by shaving the target area, antiseptic application, and drapes are placed around the target access site. 

Angioplasty is performed under moderate to deep sedation for most adult patients, but pediatric patients may require general anesthesia.

Technique or Treatment

Radial artery access should be avoided in patients with CKD who may need ESRD in the foreseeable future to preserve the radial artery for future fistula placement for hemodialysis.[19][20][21]

Radial artery: After palpation of the radial artery 2cm proximal to the radial styloid process, an arteriotomy incision is made. Next, a micropuncture needle is used to puncture the radial artery, and a hydrophilic sheath is introduced into the artery by the modified Selinger technique. Subsequently, a vasodilator is injected into the artery (usually nicardipine 500 µg or verapamil 5 mg along with nitroglycerine IV heparin 50 U/kg or Max 5000U is given to reduce the risk of radial artery thrombosis. 

Femoral artery: After palpation of the common femoral artery, 2cm below the center of the inguinal ligament at the point of maximum palpable impulse, an arteriotomy incision is made. Fluoroscopy can be used for better localization of the femoral artery, seen in the middle of the femoral head. Subsequently, a micropuncture needle is used to enter the femoral artery, and a hydrophilic sheath is placed with a modified Selinger technique.

After obtaining access, a guidewire is inserted into the artery into the target vessel. A balloon-tipped catheter is then advanced over the guidewire to the target site. At this point, when the target artery is reached, contrast (usually iohexol) is injected into the system, followed by imaging to visualize the arterial system and obtain a pre-procedure angiogram. The catheter is then advanced through the stenotic segment of the artery and inflated in an attempt to dilate the target artery and compress the atherosclerotic plaque. 

If an atherectomy is planned, then the atherectomy device is introduced through the guidewire, and the plaque is disrupted (mechanical) or ablated (laser) at this point. 

If stenting is planned, after balloon dilation, the catheter is withdrawn, and a stent of appropriate size and diameter is advanced over the guidewire. Once the stent is in the desired artery, contrast material is injected, and the stent is positioned and deployed across the lesion, followed by another angiography.

Intravascular imaging tools like Intravascular ultrasonography or Optic coherence tomography are used for assessment of the adequacy of stent deployment, including stent expansion and apposition.

If post stent deployment angiograms are deemed adequate, the guidewire is withdrawn.

Hemostasis is achieved by direct manual compression or application of a compression band to the wrist (radial) or vascular closure devices (femoral).

There is increasing evidence to support the use of radial access over femoral in percutaneous coronary interventions due to a lower risk of local bleeding complications.[14][15][16] Although, radial artery access should be avoided in patients with CKD who may need hemodialysis in the foreseeable future to preserve the radial artery for future fistula placement.

Complications

The incidence of major complications like MI, stroke, and death is variable in various angioplasty procedures. Incidence is low (< 1%) in cardiac and femoral artery procedures but higher for carotid and abdominal aortic procedures. Individual patient's risks should be assessed and evaluated using the standard morbidity scoring scales like the Revised Cardiac Risk Index ( RCRI) or American Society of Anesthesiologists (ASA) score. Predictors of worse outcomes are moribund statuses, cirrhosis, severe anemia, shock, Acute MI in the last 24hrs, renal insufficiency, cardiomyopathy, aortic or mitral valvular disease, heart failure NYHA Class III or IV, hypertension, and unstable angina.

Local Complications: Vascular complications are associated with about 6% of all angioplasty procedures.[22][23] Local perforation of the artery may occur, although the incidence is low.

Bleeding: The inability to obtain hemostasis can result in hematoma formation, pseudoaneurysm, and retroperitoneal bleeding. Bleeding complications are more common in women than men and more common in the femoral approach than the radial.[24][25] Manifestations of bleeding may range from simple hematoma at the site to significant hemodynamic instability due to massive retroperitoneal hematoma. Early recognition and volume resuscitation with crystalloids or colloids are crucial. The decision to hold DAPT depends on the individual case, but in general, it is advisable not to interrupt DAPT as benefits far outweigh the risks. Severe bleeding may require vascular surgery involvement and percutaneous methods, including balloon inflation or covered stent placement to tamponade bleeding.

Thrombosis: Less common than bleeding, but occurs more with a brachial approach than femoral.[26][27] High-risk factors for access site thrombosis are small vessel lumen, diabetes, female sex, large diameter sheath, or peripheral arterial disease.[28] Clinical features are pain or paresthesia in the affected extremity with reduced or absent distal pulses. It is advisable to have a low threshold of suspicion and urgent evaluation for vascular surgery or thrombectomy for limb preservation.

Systemic Complications

Atheroembolism: This occurs due to local trauma of arterial walls and disruption of atheromatous plaque in the transit arteries (femoral artery or aorta), which may result in small cholesterol emboli dislodging into the systemic circulation. Clinical manifestations include livedo reticularis, digital ischemia, acute kidney injury (AKI) with eosinophilic casts on urinalysis, cerebral infarction, and Hollenhorst plaques in the retina. Treatment is primarily directed at risk factor reduction and endovascular treatment for larger lesions. The overall prognosis depends on the degree of underlying atherosclerosis.

Acute Kidney Injury: Multiple factors may contribute to the AKI, including contrast exposure, atheroembolism, or reduced perfusion. Prevention with pre-procedural IV hydration and aggressive risk factor modification for atheroembolic events is advisable.

Arrhythmia: Percutaneous coronary interventions can result in a variety of conduction disturbances and arrhythmias due to irritation of the conduction system by the catheter. These include ventricular fibrillation, atrial arrhythmias such as atrial flutter or fibrillation with RVR, bradycardia (most often after injection of contrast material into the RCA), conduction disturbances (previous bundle branch block may develop into complete heart block or asystole). These are managed according to the ACLS algorithm for each type of arrhythmia.

Infection: Vascular procedures require strict sterile technique. Any infection of the access site or devices may result in severe bacteremia and sometimes even sepsis, depending on the microbial burden. All personnel involved in the procedure are required to wear masks, caps, gowns, gloves, and eyewear with strict handwashing and hygiene. All personnel is required to have Hepatitis B vaccinations. These have been emphasized in the updated 2006 Infection control guidelines by the Society for Cardiovascular Angiography and Interventions.[29]

Radiation Exposure: Serial imaging required for angioplasty procedures results in substantial radiation exposure, which theoretically increases the risk of secondary malignancies commonly myeloma, leukemia, thyroid, lung, breast, bone, and skin cancers. No clear epidemiologic studies document the association of particular cancers associated with angioplasty procedures, but future studies directed at data regarding angioplasty procedures and secondary malignancies are needed.

Hypersensitivity reactions: These are more common after drug-eluting stent placements, with the overall incidence being low.[30] Common culprit agents for allergic reactions are local anesthetic, iodinated contrast agent, protamine sulfate in diabetics who have received NPH insulin in the past, or heparin. Careful pre-procedure evaluation and avoidance of the suspect agent or pretreatment with corticosteroids and H1 antihistamines can reduce the severity of the reaction. If a severe allergic reaction develops, epinephrine may be required.

Clinical Significance

Angioplasty procedures are a minimally invasive alternative to an open surgical approach for arterial stenosis. As a result, these procedures carry significantly lower morbidity and mortality with a shorter duration of hospital stay and recovery with an acceptable risk of restenosis. Percutaneous coronary angioplasty has revolutionized the treatment of MI and unstable angina and now is the standard of care. Stenting and angioplasty are an acceptable alternative for peripheral vascular disease for suitable indications and have better recovery rates at the cost of lower revascularization rates. Carotid angioplasty procedures, however, have more risk than benefit in comparison to carotid endarterectomy procedures and are advisable only in a select group of patients.

The overall success of the interventions is also enhanced by patient compliance with diet, exercise, medications, smoking cessation, and medical optimization of comorbidities.

Enhancing Healthcare Team Outcomes

Angioplasty is a complex procedure requiring a high level of training of the performing surgeon/radiologist/cardiologist. Improved outcomes are observed in physicians trained with a higher procedural volume. Careful patient evaluation and identification of patients at high risk for complications with timely and appropriate management of immediate post-cath complications can significantly enhance outcomes. The choice between the radial vs femoral approach should take into consideration the performing surgeon's level of comfort with the newer radial approach. Individual patient assessment of bleeding and thrombosis risk to determine the duration and choice of antiplatelet agents can reduce the risk for bleeding-related complications.

Review Questions

• Access free multiple choice questions on this topic.
• Comment on this article.

References

1.

Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P., American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017 Mar 07;135(10):e146-e603. [PMC free article: PMC5408160] [PubMed: 28122885]

2.

Dotter CT. Transluminal angioplasty: a long view. Radiology. 1980 Jun;135(3):561-4. [PubMed: 7384436]

3.

Barton M, Grüntzig J, Husmann M, Rösch J. Balloon Angioplasty - The Legacy of Andreas Grüntzig, M.D. (1939-1985). Front Cardiovasc Med. 2014;1:15. [PMC free article: PMC4671350] [PubMed: 26664865]

4.

Gruntzig A. Transluminal dilatation of coronary-artery stenosis. Lancet. 1978 Feb 04;1(8058):263. [PubMed: 74678]

5.

Berkefeld J, Wagner M, du Mesnil R. Carotid Stenting in Neuroradiology : A Short Journey from the Past to Current Debates. Clin Neuroradiol. 2017 Dec;27(4):409-415. [PubMed: 28623378]

6.

Lindquist J, Schramm K. Drug-Eluting Balloons and Drug-Eluting Stents in the Treatment of Peripheral Vascular Disease. Semin Intervent Radiol. 2018 Dec;35(5):443-452. [PMC free article: PMC6363541] [PubMed: 30728660]

7.

Jaff MR, Nelson T, Ferko N, Martinson M, Anderson LH, Hollmann S. Endovascular Interventions for Femoropopliteal Peripheral Artery Disease: A Network Meta-Analysis of Current Technologies. J Vasc Interv Radiol. 2017 Dec;28(12):1617-1627.e1. [PubMed: 29031986]

8.

Lusis AJ. Atherosclerosis. Nature. 2000 Sep 14;407(6801):233-41. [PMC free article: PMC2826222] [PubMed: 11001066]

9.

Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S, Bertrand M, Fuster V., FREEDOM Trial Investigators. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012 Dec 20;367(25):2375-84. [PubMed: 23121323]

10.

Giustino G, Serruys PW, Sabik JF, Mehran R, Maehara A, Puskas JD, Simonton CA, Lembo NJ, Kandzari DE, Morice MC, Taggart DP, Gershlick AH, Ragosta M, Kron IL, Liu Y, Zhang Z, McAndrew T, Dressler O, Généreux P, Ben-Yehuda O, Pocock SJ, Kappetein AP, Stone GW. Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease: The EXCEL Trial. JACC Cardiovasc Interv. 2020 Feb 10;13(3):375-387. [PubMed: 31954680]

11.

Stone GW, Kappetein AP, Sabik JF, Pocock SJ, Morice MC, Puskas J, Kandzari DE, Karmpaliotis D, Brown WM, Lembo NJ, Banning A, Merkely B, Horkay F, Boonstra PW, van Boven AJ, Ungi I, Bogáts G, Mansour S, Noiseux N, Sabaté M, Pomar J, Hickey M, Gershlick A, Buszman PE, Bochenek A, Schampaert E, Pagé P, Modolo R, Gregson J, Simonton CA, Mehran R, Kosmidou I, Généreux P, Crowley A, Dressler O, Serruys PW., EXCEL Trial Investigators. Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease. N Engl J Med. 2019 Nov 07;381(19):1820-1830. [PubMed: 31562798]

12.

Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995 May 10;273(18):1421-8. [PubMed: 7723155]

13.

Zhu Z, Yu W. Update in the treatment of extracranial atherosclerotic disease for stroke prevention. Stroke Vasc Neurol. 2020;5(1):65-70. [PMC free article: PMC7213501] [PubMed: 32411410]

14.

Bonati LH, Lyrer P, Ederle J, Featherstone R, Brown MM. Percutaneous transluminal balloon angioplasty and stenting for carotid artery stenosis. Cochrane Database Syst Rev. 2012 Sep 12;(9):CD000515. [PubMed: 22972047]

15.

Conte MS, Pomposelli FB. Society for Vascular Surgery Practice guidelines for atherosclerotic occlusive disease of the lower extremities management of asymptomatic disease and claudication. Introduction. J Vasc Surg. 2015 Mar;61(3 Suppl):1S. [PubMed: 25721065]

16.

Dayama A, Panneton JM. Commentary: Appropriateness of Endovascular Therapy in Chronic Limb-Threatening Ischemia Patients Based on the Global Vascular Guidelines. J Endovasc Ther. 2020 Aug;27(4):614-615. [PubMed: 32495685]

17.

PLOS ONE Staff. Correction: Drug-coated balloon versus conventional balloon angioplasty of hemodialysis arteriovenous fistula or graft: A systematic review and meta-analysis of randomized controlled trials. PLoS One. 2020;15(5):e0233923. [PMC free article: PMC7156061] [PubMed: 32442223]

18.

Cole TS, Mezher AW, Catapano JS, Godzik J, Baranoski JF, Nakaji P, Albuquerque FC, Lawton MT, Little AS, Ducruet AF. Nationwide Trends in Carotid Endarterectomy and Carotid Artery Stenting in the Post-CREST Era. Stroke. 2020 Feb;51(2):579-587. [PubMed: 31847750]

19.

Rychlik J, Hornacek I, Tejc M, Petrikovits E, Klimsa Z. Retrospective analysis of coronary interventions in a single centre and comparison of specific differences between radial and femoral access. Acta Cardiol. 2019 Aug;74(4):325-330. [PubMed: 30193077]

20.

Tomassini F, Tarantino F, Cerrato E, Quadri G, Rolfo C, Varbella F. Choice of vascular access in primary PCI. Minerva Cardioangiol. 2018 Aug;66(4):400-410. [PubMed: 29393606]

21.

Romagnoli E, Biondi-Zoccai G, Sciahbasi A, Politi L, Rigattieri S, Pendenza G, Summaria F, Patrizi R, Borghi A, Di Russo C, Moretti C, Agostoni P, Loschiavo P, Lioy E, Sheiban I, Sangiorgi G. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol. 2012 Dec 18;60(24):2481-9. [PubMed: 22858390]

22.

Muller DW, Shamir KJ, Ellis SG, Topol EJ. Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures. Am J Cardiol. 1992 Jan 01;69(1):63-8. [PubMed: 1729869]

23.

Carrozza JP, Baim DS. Complications of directional coronary atherectomy: incidence, causes, and management. Am J Cardiol. 1993 Oct 18;72(13):47E-54E. [PubMed: 8213570]

24.

Yamamoto K, Natsuaki M, Morimoto T, Shiomi H, Watanabe H, Yamaji K, Watanabe H, Kato T, Saito N, Ando K, Kadota K, Furukawa Y, Kimura T., CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators. Transradial vs. Transfemoral Percutaneous Coronary Intervention in Patients With or Without High Bleeding Risk Criteria. Circ J. 2020 Apr 24;84(5):723-732. [PubMed: 32188831]

25.

Argulian E, Patel AD, Abramson JL, Kulkarni A, Champney K, Palmer S, Weintraub W, Wenger NK, Vaccarino V. Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions. Am J Cardiol. 2006 Jul 01;98(1):48-53. [PubMed: 16784919]

26.

Slater J, Selzer F, Dorbala S, Tormey D, Vlachos HA, Wilensky RL, Jacobs AK, Laskey WK, Douglas JS, Williams DO, Kelsey SF. Ethnic differences in the presentation, treatment strategy, and outcomes of percutaneous coronary intervention (a report from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol. 2003 Oct 01;92(7):773-8. [PubMed: 14516874]

27.

Kennedy JW. Complications associated with cardiac catheterization and angiography. Cathet Cardiovasc Diagn. 1982;8(1):5-11. [PubMed: 7060118]

28.

Cannan CR, Yeh W, Kelsey SF, Cohen HA, Detre K, Williams DO. Incidence and predictors of target vessel revascularization following percutaneous transluminal coronary angioplasty: a report from the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Am J Cardiol. 1999 Jul 15;84(2):170-5. [PubMed: 10426335]

29.

Chambers CE, Eisenhauer MD, McNicol LB, Block PC, Phillips WJ, Dehmer GJ, Heupler FA, Blankenship JC., Members of the Catheterization Lab Performance Standards Committee for the Socitey for Cardiovascular Angiography and Interventions. Infection control guidelines for the cardiac catheterization laboratory: society guidelines revisited. Catheter Cardiovasc Interv. 2006 Jan;67(1):78-86. [PubMed: 16331649]

30.

Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, Davidson CJ, McKoy JM, Raisch DW, Whisenant BK, Yarnold PR, Belknap SM, West DP, Gage JE, Morse RE, Gligoric G, Davidson L, Feldman MD. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol. 2006 Jan 03;47(1):175-81. [PubMed: 16386683]

Disclosure: Hafsa Majeed declares no relevant financial relationships with ineligible companies.

Disclosure: Yuvraj Chowdhury declares no relevant financial relationships with ineligible companies.